Breakthrough hepatitis C medicines remain in regulatory limbo

Over the last decade the treatment of hepatitis C, a virus that can infect and damage the liver, has been revolutionised by a new class of medicines called direct acting antivirals. Catherine Tomlinson investigates the regulatory obstacles that are limiting access to these breakthrough medicines in South Africa.

Read More

COVID-19: How rugby legend Broadhurst Cona beat COVID-19

In his illustrious career, Broadhurst (Broadness) Cona, learnt to fight hard on the rugby field and never gave up until the final whistle. It is this same spirit that Cona brought to another fight – surviving COVID-19 as a 73-year-old. Siyabonga Kamnqa paid Cona a visit.

Read More